When did ADMA Biologics report Q2 2025 earnings?

ADMA Biologics (ADMA) reported Q2 2025 earnings on August 6, 2025 after market close.

What were ADMA Biologics's Q2 2025 revenue and EPS?

ADMA Biologics reported revenue of $122.0M and eps of $0.15 for Q2 2025.

Did ADMA Biologics beat estimates in Q2 2025?

Revenue missed the consensus estimate of $130.3M by $8.3M. EPS beat the consensus estimate of $0.14 by $0.01.

How did ADMA Biologics's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 13.8% from $107.2M a year earlier and eps grew 15.4% from $0.13.

Where can I find ADMA Biologics's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001140361-25-029177) directly on SEC EDGAR. The filing index links above go to sec.gov.

ADMA Biologics ADMA Q2 2025 earnings

Reported August 6, 2025 · After market close

Revenue$122.0MMiss by $8.3M

EPS$0.15Beat by $0.01

Revenue estimate$130.3M

EPS estimate$0.14

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$125.3M

EPS estimate$0.16

Financials

Q2 2025

Income statement

See full

Revenue$122.0M+13.8%

Gross profit$67.2M+17.0%

Operating income$42.8M+9.2%

Net income$34.2M+6.7%

EPS (diluted)$0.14+7.7%

Balance sheet

See full

Cash & equivalents$90.3M+2.3%

Total debt$10.4M+1.0%

Total equity$398.3M+112%

Total assets$558.4M+48.3%

Cash flow

See full

Operating cash flow$21.1M-53.7%

CapEx$2.4M+17.2%

Free cash flow$18.7M-57.1%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$4.26B+64.4%

Enterprise value$4.18B+66.3%

P/E20.4×-54.1×

P/S9×+1.1×

Profitability

See full

Gross margin53%+6.9pp

Operating margin32.8%+7.4pp

Net margin44.1%+33.5pp

FCF margin13.9%-6.3pp

Returns & leverage

See full

Return on equity71.2%+50.5pp

Debt / equity0×0.0×

Current ratio5.3×-1.5×

Segments

By segment

See full

ADMA Bio Manufacturing$121.9M+14.8%

Plasma Collection Centers--100%

Versus estimates

Revenue

Q1 2026$114.5MMiss by $25.5M Q4 2025$139.2MMiss by $437.0K Q3 2025$134.2MMiss by $5.6M

Q2 2025$122.0MMiss by $8.3M

Q1 2025$114.8MMiss by $7.0M Q4 2024$117.5MBeat by $8.9M

Diluted EPS

Q1 2026$0.19Miss by $0.00 Q4 2025$0.20Beat by $0.02 Q3 2025$0.16In line

Q2 2025$0.15Beat by $0.01

Q1 2025$0.14Miss by $0.02 Q4 2024$0.14Miss by $0.01

Ask the moment ADMA Biologics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did ADMA Biologics report Q2 2025 earnings?: ADMA Biologics (ADMA) reported Q2 2025 earnings on August 6, 2025 after market close.
What were ADMA Biologics's Q2 2025 revenue and EPS?: ADMA Biologics reported revenue of $122.0M and eps of $0.15 for Q2 2025.
Did ADMA Biologics beat estimates in Q2 2025?: Revenue missed the consensus estimate of $130.3M by $8.3M. EPS beat the consensus estimate of $0.14 by $0.01.
How did ADMA Biologics's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 13.8% from $107.2M a year earlier and eps grew 15.4% from $0.13.
Where can I find ADMA Biologics's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001140361-25-029177) directly on SEC EDGAR. The filing index links above go to sec.gov.